Associazione Nazionale Medici Cardiologi Ospedalieri

www.anmco.it

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
Intravascular lithotripsy for the treatment of severely calcified coronary stenosis in Acute Myocardial Infarction
Anno:
2023
Background Little is known about intraprocedural and mid-term results of intravascular lithotripsy (IVL) use in patients with acute MI. Methods In Our retrospective analysis, data from 21 Centers in Italy and Spain between January 2020 and November 2021 were collected. Patients were allocated to the AMI-group when IVL was…
Leggi di più
THE ROLE OF PREPARTICIPATION SCREENING IN DETECTING SILENT CORONARY ARTERY DISEASE IN MASTER ATHLETES: A WAY TO PREVENT EXERCISE-RELATED ADVERSE CARDIOVASCULAR EVENTS
Anno:
2023
Regular exercise reduces morbidity and mortality from cardiovascular diseases through cardiac and systemic adaptations including the increased coronary blood flow, an improved endothelial function, a slower progression of atherosclerotic processes as well as the stabilization of pre-existing lesions. However, long-term exercise is frequently associated with adverse cardiovascular events in…
Leggi di più
COVID-19 DIAGNOSIS AND MORTALITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION ADMITTED IN ITALY DURING THE NATIONAL OUTBREAK
Anno:
2023
Background and objective: There are limited data on the clinical impact of Covid-19 in patients with acute myocardial infarction (AMI). Aim of this work is to assess the impact of Covid-19 infection on mortality in AMI patients admitted during the national outbreak in Italy. Methods: Retrospective nationwide cohort study…
Leggi di più
Prognostic Impact of Percutaneous Coronary Intervention in Chronic Dialysis Patients with Acute Myocardial Infarction: Findings From the Lombardy Health Database.
Anno:
2023
Background. Patients on chronic dialysis are less likely to receive percutaneous coronary intervention (PCI) for treatment of acute myocardial infarction (AMI). This is due to the lack of evidence from randomized trials, concerns about possible PCI-related side effects, and multimorbidity. Thus, routine use of PCI for treatment of dialysis…
Leggi di più
Onde T negative all’ECG: non solo cardiomiopatia ipertrofica
Anno:
2023
BACKGROUND La cardiomiopatia aritmogena è ancora considerata, al giorno d’oggi, una patologia rara e di difficile diagnosi, però un fondato sospetto clinico-strumentale ed un corretto iter diagnostico possono svelare precocemente questa patologia pur partendo da comuni reperti strumentali. CASO CLINICO In Settembre si presentava presso la nostra struttura un…
Leggi di più
CHALLENGING DIAGNOSIS OF A TRIPLE CARDIAC PATHOLOGY: TRANSTHYRETIN AMYLOIDOSIS WITH ASPECTS OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY AND ANOMALOUS CORONARY ARTERY.
Anno:
2023
A 70 years-old man with a history of systemic hypertension and surgically treated bilateral carpal tunnel was referred for dyspnea on exertion for few months. At physical examination a systolic heart murmur exacerbated by Valsalva maneuver was appreciated; no signs of heart failure. EKG with low-voltage QRS is shown…
Leggi di più
VERSAMENTO PLEURICO E PERICARDICO SEVERO: QUALE DRENARE PRIMA?
Anno:
2023
Introduzione In pz con neoplasia, un severo versamento pleurico e pericardico sono frequente riscontro. In questi pz il polmone non ha la capacità di riespandersi completamente per infiltrazione (“lung entrapment”), una toracentesi ad alto volume può causare un edema idrostatico da riespansione (REPO). REPO è una condizione rara, ad elevata mortalità e…
Leggi di più
Early and mid-term results from the resilia aortic tissue valve Italian Registry (RES-ITA)
Anno:
2023
Objective: The objective of our study is to evaluate safety, hemodynamic performance and durability of the new generation aortic bioprosthesis with Resilia Tissue. Methods: RES-ITA Registry is the Italian multicenter registry created in 2017, enrolling patients who underwent isolated or combined AVR with Resilia tissue valve. The Registry was recently…
Leggi di più
Very Long Term Follow up of Primary Transcatheter Patent Foramen Ovale Closure for Migraine Cure
Anno:
2023
Background. Results of previous trials about PFO closure as a treatment for migraine are still doubtful and inconclusive. We sought to evaluate the long-term (>10 years) effectiveness of migraine treatment by means of patent foramen ovale (PFO) closure. Methods. From 2006 to 2010, 86 patients (68 female, mean age…
Leggi di più
LE EMERGENZE IPERTENSIVE: I DATI DELLA PRATICA CLINICA A CONFRONTO CON LE INDICAZIONI DELLE LINEE GUIDA
Anno:
2023
BACKGROUND: Le linee guida ESH 2018 hanno rimodulato i target terapeutici nelle Emergenze Ipertensive (EI) verso riduzioni più intense (<140/90 mmHg) e più rapide. Il danno d'organo cardiologico durante EI è rappresentato dall'infarto miocardico, dall'angina instabile, dall'edema polmonare e dalla dissezione aortica. Ad oggi è ancora poco chiaro quanto…
Leggi di più

A.N.M.C.O. – Via La Marmora 36, 50121 Firenze (Italy) – Partita I.V.A. 05469530488 – Codice Fiscale 01301130488 – Privacy
www.anmco.it | segreteria@anmco.it

Seguici su

Facebook Twitter Youtube Linkedin Instagram Telegram